-transparent.png){kind=logo}
The effects of both opiate agonists and the opiate antagonist naloxone were examined in a rodent model of tardive dyskinesia (TD). Chronic (approximately 20 weeks) administration of fluphenazine resulted in the emergence of vacuous chewing mouth movements (VCMs), a response which may be a useful model for this disorder. Fluphenazine-induced VCMs were not affected by a variety of selective opiate agonists administered intracerebroventricularly, but were potently suppressed by subcutaneous administration of the opiate antagonist naloxone. These findings suggest that increased opiate transmission may contribute to the pathogenesis of TD. Further investigation of the role of opiate antagonists in treating this disorder are warranted.
A J Stoessl, and
E Polanski, and
H Frydryszak
January 1987,
Psychopharmacology,
A J Stoessl, and
E Polanski, and
H Frydryszak
December 1985,
Biological psychiatry,
A J Stoessl, and
E Polanski, and
H Frydryszak
April 1995,
Neuropharmacology,
A J Stoessl, and
E Polanski, and
H Frydryszak
October 1981,
Drug and therapeutics bulletin,
A J Stoessl, and
E Polanski, and
H Frydryszak
July 1996,
Pharmacology, biochemistry, and behavior,
A J Stoessl, and
E Polanski, and
H Frydryszak
September 2006,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
A J Stoessl, and
E Polanski, and
H Frydryszak
October 1988,
Psychiatry research,
A J Stoessl, and
E Polanski, and
H Frydryszak
January 2002,
Neuroscience,
A J Stoessl, and
E Polanski, and
H Frydryszak
January 2003,
Neuroscience,
A J Stoessl, and
E Polanski, and
H Frydryszak
January 2000,
Neuroscience,
